Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. The update does not alter study details or other content visible on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedA new Publication entry was added under Publications: Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER (J Immunother Cancer, 2026). The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check48 days agoChange DetectedShow glossary toggle added; new labels include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' while the previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page shows a new revision label: Revision: v3.3.4, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded extensive Location sections listing study sites by country/region (e.g., United States by state, Argentina provinces, Australia states, Mexico regions, etc.), and noted the Revision: v3.3.3.SummaryDifference2%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.